Tourniquet Systems Market (2026 - 2033)

Tourniquet Systems Market Summary

The global tourniquet systems market was valued at USD 569.6 million in 2025 and is projected to grow from USD 615.7 million in 2026 to USD 1,100 Million in 2033, at a CAGR of 8.1% from 2026 to 2033. The North America market dominated with a revenue share of approximately 45.0% in 2025. Key factors such as the increasing geriatric population's increased susceptibility to orthopedic conditions and growing patient awareness are driving the market growth.

The rising incidence of road accidents, sports injuries, and trauma cases has increased demand for tourniquet systems. These devices play a critical role in emergency and trauma care by controlling severe bleeding and improving patient survival in life-threatening situations. Technological advancements have further improved the effectiveness and safety of tourniquet systems by enabling better pressure control and monitoring, thereby reducing complications such as nerve damage and ischemia. For instance, in February 2026, the Naperville Fire Department in Illinois became the first in the Edward Hospital EMS system to deploy the SAM Junctional Tourniquet for severe hemorrhage control in hard-to-reach anatomical areas such as the pelvis and groin, highlighting the expanding adoption of advanced tourniquet systems in civilian emergency care.

Tourniquets are crucial in hospitals, particularly during orthopedic surgeries, where external bleeding must be controlled with direct pressure. These devices are also essential in emergency situations involving life-threatening limb hemorrhages or limb amputations with multiple bleeding points, enabling rapid hemorrhage control and improving patient stabilization during critical emergencies.

Increasing healthcare expenditure, improved access to surgical care, and growing investments in emergency medical infrastructure are further supporting market growth. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) maintain strict quality and safety standards for tourniquet systems through medical device regulations, ensuring product reliability and patient safety.

Analyst Perspective

The market is expanding steadily, driven by the rising incidence of road accidents, sports injuries, and trauma cases requiring rapid hemorrhage control in emergency settings. Increasing adoption in pre-hospital care and emergency medical services is further driving demand, with recent real-world deployment of advanced junctional tourniquets in EMS systems highlighting the growing integration of military-grade bleeding-control solutions into civilian healthcare. This trend reflects the growing emphasis on improving patient survival through faster, more effective hemorrhage management. From a broader industry perspective, technological advancements such as improved pressure-control systems and integrated safety-monitoring features are enhancing device reliability and minimizing complications such as nerve damage and ischemia. Hospitals continue to rely heavily on tourniquet systems during orthopedic, trauma, and vascular surgeries, where maintaining a controlled bloodless surgical field is critical. In addition, stringent regulatory oversight for medical device quality and safety, coupled with rising healthcare investments in emerging economies, is supporting market expansion, making surgical tourniquets a critical and evolving segment within emergency and surgical care.

Product Insights

The tourniquet cuffs segment emerged as the market leader, capturing the highest revenue share of around 73.0%. The rising use of tourniquet cuffs in orthopedic procedures, lower-limb injuries, and joint replacement surgeries is projected to propel growth in this segment in the coming years. The segment is also benefiting from increasing demand for disposable and reusable cuff variants designed to improve patient safety, comfort, and infection control. In addition, advancements in cuff materials and ergonomic designs are enhancing pressure distribution and reducing the risk of tissue damage during prolonged surgical procedures.

On the contrary, the tourniquet instrument segment is anticipated to exhibit a significant CAGR from 2026 to 2033. Technological advancements are making tourniquet instruments more efficient, user-friendly, and safer. Increasing surgical procedures and rising trauma cases are projected to drive growth during the forecast period. The growing adoption of automated and digital tourniquet systems with advanced pressure monitoring is further supporting segment expansion. In addition, increasing demand for precision-driven surgical equipment in hospitals and ambulatory surgical centers is expected to accelerate the adoption of advanced tourniquet instruments.

Cuff Type Insights

The pneumatic cuff type accounted for the largest market revenue share, at approximately 88.0% in 2025, due to higher demand. They are widely used due to their ability to provide standardized pressure. Technological advancements, such as SourceMark Medical's disposable cuffs, are expected to further drive segment growth. These sterile, single-use cuffs reduce costs, infection risks, and bacterial transfer, making them a valuable asset for clinicians. The segment is further driven by the increasing number of orthopedic and trauma surgeries, in which precise pressure control is essential for minimizing blood loss and improving surgical outcomes. In addition, according to the American Joint Replacement Registry, over 3.7 million hip and knee arthroplasty procedures had been recorded cumulatively in the U.S. by 2024, reflecting strong procedural demand that supports the adoption of pneumatic cuffs.

Non-pneumatic cuffs are expected to witness significant growth with a CAGR over the forecast period. Non-pneumatic tourniquets, which use mechanical or guiding structures, are gaining popularity for their minimal invasiveness and cost-effectiveness. They are often used in prehospital and point-of-care scenarios, but can also be used in operating rooms. Their affordability makes them increasingly desirable in healthcare settings where finances are a concern. The segment is further driven by increasing adoption in military, emergency response, and ambulatory care settings, where rapid deployment and ease of use are critical. In addition, growing demand from emerging economies with cost-sensitive healthcare infrastructure is expected to further support segment growth during the forecast period.

Application Insights

Hospitals led in market share, accounting for 46.0% of total revenue in 2025. Tourniquet systems are widely utilized in hospitals as a crucial tool for addressing life-threatening external hemorrhages resulting from lower limb injuries. Increasing average income levels ensure convenient access and affordability in hospital settings. Advancements in diagnostics, along with a diverse array of treatments such as tourniquet systems, are anticipated to fuel growth in this sector. Hospitals and trauma systems continue to formally integrate tourniquet-based hemorrhage control into emergency and surgical protocols, particularly through expanded Stop the Bleed implementation and first responder training requirements.

The non-institutional use segment is expected to grow at a steady CAGR during the forecast period. Increasing awareness about first aid and emergency medical procedures among the general public is driving demand for personal medical kits. Technological advancements have led to the development of user-friendly, cost-effective tourniquet systems, making them more accessible. Moreover, the rise in outdoor activities and adventurous sports has spurred the development of user-friendly, cost-effective tourniquet systems, making them more accessible to non-professional users.

Regional Insights

The tourniquet systems market in North America led the global market in 2025, capturing a significant revenue share of over 45.0%, driven by well-established healthcare infrastructure, a large target population, and high adoption of advanced technological systems. A BioMed Central study conducted in North America found that the region has a higher prevalence of hip osteoarthritis than other regions. The region also benefits from a high volume of orthopedic and trauma surgeries, particularly knee and hip replacement procedures, which drive consistent demand for tourniquet systems. In addition, increasing investments in emergency medical services and widespread adoption of advanced hemorrhage-control solutions across hospitals and trauma centers are further supporting regional market growth.

U.S. Tourniquet Systems Market Trends

The tourniquet systems market in the U.S. emerged as a frontrunner, capturing more than 75.0% market share. The country’s dominance in the global industry is driven by its well-established healthcare infrastructure and large patient pool. Physicians in the U.S. promote public awareness and training for rapid bleeding control techniques among laypeople, law enforcement, and firefighters. This effort aims to empower individuals to respond effectively in emergencies, thereby significantly increasing demand for related products.

Europe Tourniquet Systems Market Trends

The tourniquet systems market in Europe is expected to grow significantly from 2026 to 2033. This growth can be attributed to various factors, including the rising demand for minimally invasive surgeries that require specialized tourniquets capable of controlling blood flow in smaller areas. In addition, the growing geriatric population and increasing prevalence of orthopedic disorders such as osteoarthritis are driving demand for joint replacement and trauma procedures across the region. Furthermore, favorable reimbursement policies and well-established healthcare systems are supporting the adoption of advanced tourniquet systems in surgical settings.

Germany tourniquet systems market holds a prominent position in the European market. Sales of surgical tourniquets in Germany are expected to increase substantially in the coming year. The rising demand in Germany can be attributed to renowned tourniquet companies, proficient medical professionals, and the greater utilization of cutting-edge technologies. The market is further supported by the high volume of orthopedic and trauma surgeries performed annually, creating strong demand for reliable bleeding-control solutions. In addition, Germany’s advanced hospital infrastructure and increasing adoption of technologically advanced surgical equipment are expected to drive market growth.

The tourniquet systems market in the UK is expected to grow rapidly in the coming years, owing to the presence of key companies in the region and high technological advancement. The demand for tourniquet cuffs is expected to rise due to the growing prevalence of chronic diseases such as diabetes and cardiovascular diseases. Tourniquet cuffs are commonly used in medical procedures and surgeries to control bleeding and ensure patient safety. Moreover, rising emergency admissions related to road accidents and trauma cases are increasing the demand for tourniquet systems in hospitals and prehospital care settings. The growing emphasis on emergency preparedness and hemorrhage control training across healthcare facilities is further supporting market expansion.

Asia Pacific Tourniquet Systems Market Trends

The tourniquet systems market in the Asia Pacific is projected to grow at a steady rate during the forecast period. This growth can be attributed to various factors, including rapid population growth and increasing healthcare expenditure in countries such as India, China, and Indonesia. As these economies continue to flourish, the demand for medical devices and tourniquets is expected to rise.

India tourniquet systems market is expected to grow lucratively owing to a surge in road accidents and falls, driven by a larger population and an increase in the number of vehicles on the road. This has created a pressing need for emergency tourniquets. Furthermore, the market is characterized by a mix of global and local players, as well as the emergence of domestic companies.

Key Tourniquet Systems Company Insights

The surge in competition is driving rapid technological progress, prompting companies to enhance their products through extensive research and development efforts. Leading companies are adopting various strategic approaches such as mergers and acquisitions, partnerships, and new product introductions to bolster their market presence.

Key Tourniquet Systems Companies

The following key companies have been profiled for this study on the tourniquet systems market:

• Delfi Medical Innovations Inc.

• AneticAid

• Zimmer Biomet

• DESSILLIONS & DUTRILLAUX

• Stryker

• VBM Medizintechnik GmbH

• Oneg HaKarmel Medical Devices

• ulrich GmbH & Co. KG

• Hammarplast Medical AB

Recent Developments

• In October 2025, Zimmer Biomet acquired Monogram Technologies, an AI-driven orthopedic robotics company, to expand its advanced surgical technology portfolio. This acquisition strengthens Zimmer Biomet’s orthopedic surgical ecosystem and is expected to promote broader adoption of advanced surgical tools, including tourniquet systems for orthopedic and joint-replacement procedures.
• In June 2024, Technimount E.M.S. Holding Inc. signed a distribution agreement in Canada with Compression Works Inc. to distribute the Abdominal Aortic and Junctional tourniquet-stabilized (AAJT-S).

Tourniquet Systems Market Report Scope

Global Tourniquet Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global tourniquet systems market report based on product, cuff type, application, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tourniquet System
  • Tourniquet Instruments
  • Tourniquet Cuffs
• Cuff Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pneumatic
  • Non-pneumatic
    • Disposable
    • Reusable
• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Setting
  • Non-institutional Use
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait